A Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIs
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Dong Wook Kim
the Catholic University of Korea's St. Mary's Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Territorial State Budgetary Institution
Barnaul, Russia
Not, yet, recruiting - Federal State Budgetary Institution of Science
Kirov, Russia
Recruiting - Federal State Budgetary Institution
Moscow, Russia
Not, yet, recruiting - Hematology Centre Based on City Clin. Hosp. N.A. S.P. Botkin
Moscow, Russia
Recruiting - Federal State Budgetary Institution
Saint Petersburg, Russia
Recruiting - Federal State Budgetary Institution
Saint Petersburg, Russia
Recruiting
- Uijeongbu Eulji Medical Center, Eulji University
Uijeongbu-si, Gyeonggi-do, South Korea
Dong-Wook KimRecruiting
- Ankara University Medical Faculty
Ankara, Turkey (Türkiye)
Recruiting - Gazi University Medical Faculty
Ankara, Turkey (Türkiye)
Recruiting - Istanbul University Cerrahpasa - Cerrahpasa Medical Faculty
Istanbul, Turkey (Türkiye)
Recruiting - Ege University Medical Faculty
Izmir, Turkey (Türkiye)
Recruiting - Mersin University Medical Faculty
Mersin, Turkey (Türkiye)
Recruiting - Ondokuz Mayis Univ. Med. Fac.
Samsun, Turkey (Türkiye)
Recruiting
- Ci Cherkasy Regional Oncological Dispensary of Crc
Cherkassy, Ukraine
Recruiting - Ctpi Chernihiv Regional Oncological Dispensary
Chernihiv, Ukraine
Recruiting - Ci Dnipropetrovsk Cmch #4 of Dnipropetrovsk Rc
Dnipro, Ukraine
Recruiting - Institute of Cr of Si Nsc of Radiation Medicine of Namsu H&t Unit
Kyiv, Ukraine
Recruiting - Si Institute of Blood Pathology and Transfusion Medicine of Amsu
Lviv, Ukraine
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 25 Jun 2018
- Primary completion
- 30 Jun 2026
- Completion
- 31 Dec 2027
- Last update posted
- 28 Oct 2024
- Registered enrollment
- 173
- Registry id
- NCT03459534
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.